Pharmaceutical drug delivery systems help administer therapeutic drugs and biologicals to patients in a safe and controlled manner. Oral drug delivery remains the most convenient and widely accepted route of delivery for patients and caregivers alike owing to ease of ingestion and minimal healthcare resources required. With advancements in sustained release formulations and coating technologies, oral drug delivery systems are experiencing increased adoption for chronic disease management. The global Pharmaceutical Drug Delivery Market is estimated to be valued at US$ 2307.27 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Extended-release oral dosage forms have seen tremendous growth in the pharmaceutical drug delivery market owing to improved patient compliance and therapeutic efficacy. Capsules and pills embedded with polymer coatings that peel or erode in a controlled manner in the gastrointestinal tract are enabling once-daily or weekly dosing compared to multiple doses per day required with conventional formulations. Various biodegradable and stimuli responsive polymers are being studied to achieve accurate release profiles and target different regions of the gut for both systemic and local drug action. This has enhanced convenience and driven adoption of sustained release technologies.
Segment Analysis
The global pharmaceutical drug delivery market is dominated by the oral drug delivery segment. Oral drug delivery is the most convenient and commonly adopted route of drug delivery. It accounts for nearly 40% of the total drug delivery market owing to ease of ingestion and better patient compliance for medication. New advanced formulations and technologies are being employed to develop enhanced oral drug delivery systems with improved drug absorption and bioavailability.
Key Takeaways
The Global Pharmaceutical Drug Delivery Market Size is expected to witness high growth in the forecast period driven by increasing incidence of chronic diseases, rising geriatric population, and growing demand for advanced drug delivery technologies.
Regional analysis: North America dominates the global pharmaceutical drug delivery market and is expected to maintain its leading position throughout the forecast period. This can be attributed to growing prevalence of chronic diseases, well-established healthcare infrastructure, high healthcare spending, and presence of major players in the region. Asia Pacific region is anticipated to witness highest growth due to increasing healthcare expenditures, growing middle class population, rising incidences of diseases, and technological advancements.
Key players operating in the pharmaceutical drug delivery market are Thermo Fisher Scientific Inc., Corning Incorporated, Lonza Group Ltd., Avantor, Inc., Synthecon Incorporated, Bico Group, and ReproCELL Incorporated. Thermo Fisher Scientific Inc. and Becton, Dickinson, and Company are establishing robust market presence through collaborations and new product launches. 3D Biotek, LLC and InSphero AG are actively focusing on developing advanced 3D cell culture-based drug delivery technologies.
For More Insights, Read: https://www.newswirestats.com/pharmaceutical-drug-delivery-market-trends-growth-and-regional-outlook-2023-2030/
